Fierce BioTech
OCTOBER 31, 2024
These protein designs often require complex cloning strategies, including minimal sequence designs and repetitive motifs, which can be tedious to clone without modern DNA synthesis techniques. Ansa Biotechnologies was founded by scientists specifically to address the needs of customers like the Gao Lab.
The Pharma Data
JANUARY 6, 2021
Join this webinar to learn: The pragmatic short-term opportunities created through digital transformation. Dr. Pepe has a PhD in cancer biology and DNA repair and extensive experience in development and validation of cell-based assays. This webinar will take place at: 9am EST. 6am PST.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce BioTech
JUNE 15, 2023
Collecting DNA methylation data by WGBS offers valuable insights into disease origin, predisposition, and treatment response, potentially guiding therapeutic strategies. Click here to login. Listing Image Zymo_LogoListing_7122023.png On Demand Start Date Wed, 07/26/2023 - 12:00
Fierce BioTech
FEBRUARY 14, 2025
Nonviral CRISPR-based knock-in of chimeric antigen receptor transgenes into T cells for cell therapy dwunderlin Fri, 02/14/2025 - 14:52 Thu, 04/03/2025 - 11:00 Resource Type Webinar Krishanu Saha, PhD Max Sellman Join us for an insightful webinar on the latest advancements in cell and gene therapy, focusing on the innovative Cas9-CLIPT technology.
Fierce BioTech
OCTOBER 26, 2023
The company has developed a disruptive DNA synthesis platform that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. The company has developed a disruptive DNA synthesis platform that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip.
Fierce BioTech
JUNE 6, 2023
Capture the Magic: Enhancing cfDNA Open-format Isolation for Robust, Reproducible Downstream Analysis pesurya Tue, 06/06/2023 - 14:16 Wed, 07/12/2023 - 11:00 Resource Type Webinar Duration 60 Minutes There has been a significant need for a reliable, consistent plasma collection and DNA extraction workflow in the field of liquid biopsy.
Conversations in Drug Development Trends
JUNE 21, 2024
Although there are a range of efficacies across different tumor types that require a greater understanding, the use of circulating tumor DNA profiles holds promise for personalized treatment strategies that better target the drug for the patient, potentially revolutionizing how ADCs are deployed in clinical practice.
Expert insights. Personalized for you.
64 
Let's personalize your content